IndiaMTF — home
Stock

Panacea Biotec — MTF Book

PANACEABIO · Panacea Biotec Limited
Health Technology

Daily Margin Trading Facility book for Panacea Biotec across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Panacea Biotec’s MTF book?

Panacea Biotec Limited (PANACEABIO) has ₹22 crore funded under Margin Trading Facility across NSE and BSE as of 20 Aug 2026 — 0.01% of India’s MTF book, ranking #993. Over 1M (the last 30 trading days) the funded value has fallen 13.0%, with the number of shares under margin down 11.9%.

Funded value
₹22 Cr
as of 20 Aug 2026
Rank in book
#993
1,401 days tracked
Share of book
0.01%
of the whole NSE + BSE book
Peak funded
₹27 Cr
on 24 Jul 2026
Largest single-day addition
+₹3 Cr
on 08 Jan 2026
Largest single-day unwind
−₹2 Cr
on 09 Nov 2021
Free-float market cap
₹517 Cr
full market cap ₹1,879 Cr · 27.5% free float · Small cap
MTF share of free float
2.76%
1.3× the median small cap · 3.3× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.69%1.68%2.67%3.65%May 2025Aug 2026
View as table: share of free float on margin16 months
Month-end% of free float
20 Aug 2026†2.762%
31 Jul 20263.131%
30 Jun 20263.094%
29 May 20262.999%
30 Apr 20263.312%
30 Mar 20262.816%
27 Feb 20262.994%
30 Jan 20263.096%
31 Dec 20252.656%
28 Nov 20252.618%
31 Oct 20252.299%
30 Sep 20252.271%
29 Aug 20251.823%
31 Jul 20251.574%
25 Jun 2025†1.133%
30 May 20251.032%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How PANACEABIO’s funded book divides across the two exchanges, as of 20 Aug 2026.
NSE
NSE ₹21 Cr · 98.1%BSE ₹0 Cr · 1.9%

MTF vs Price

Margin-funded outstanding for PANACEABIO in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where PANACEABIO has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

PANACEABIO — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
20 Aug 202622−₹10.01%993
19 Aug 202622+₹00.01%978
18 Aug 202622+₹00.01%984
17 Aug 202622−₹00.01%984
14 Aug 202622+₹00.01%982
13 Aug 202622+₹00.01%981
12 Aug 202622+₹00.01%981
11 Aug 202622+₹00.01%977
10 Aug 202622−₹10.01%972
07 Aug 202623+₹00.02%952
06 Aug 202623+₹10.02%950
05 Aug 202622−₹00.01%960
04 Aug 202622−₹20.02%949
03 Aug 202624−₹00.02%914
31 Jul 202624−₹10.02%910
30 Jul 202625−₹00.02%895
29 Jul 202626−₹00.02%891
28 Jul 202626−₹10.02%889
27 Jul 202627−₹00.02%868
24 Jul 202627+₹00.02%864
23 Jul 202627+₹00.02%865
22 Jul 202626+₹00.02%872
21 Jul 202626+₹10.02%874
20 Jul 202625+₹00.02%899
17 Jul 202625+₹10.02%894
16 Jul 202624−₹00.02%905
15 Jul 202624+₹00.02%900
14 Jul 202624−₹00.02%899
13 Jul 202624−₹00.02%896
10 Jul 202624—0.02%887
Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.